Biotech Expertise Polymun's specialization in contract development and manufacturing of biopharmaceuticals, including biosimilars and vaccine components, positions it as a key partner for clients seeking manufacturing outsourcing, especially those focusing on immunology and vaccine applications.

Regulatory Compliance With current GMP certification and an Austrian pharmaceutical license, Polymun adheres to rigorous EU standards, making it an attractive partner for organizations needing certified manufacturing capabilities for global markets.

Innovation & Partnerships Polymun's contribution to COVID-19 vaccine development and its biosimilar portfolio highlight its capability for innovative collaborations, presenting opportunities for companies seeking to expand or accelerate vaccine and biologic pipelines.

Market Niche Operating within a niche of advanced biopharmaceutical formulation, including liposomal and LNP technologies, Polymun offers targeted solutions for clients developing next-generation drug delivery systems.

Growth Potential Although currently with modest revenue, Polymun's focus on biosimilars and vaccine components provides scalable growth opportunities aligned with increasing global demand for biologics and immunotherapies.